Next, we evaluated the possible ferroptotic ROS‐activated pathways in HNSCC cells by co‐treatment with FIN56 and different inhibitors for inflammatory signal pathways, including a STAT3 inhibitor, a STAT1 inhibitor, and an NF‐κB inhibitor. Here, STAT3 is linked to head and neck squamous cell carcinoma.